Back to mobile site

H.C. Wainwright Downgrades Capricor Therapeutics (CAPR) to Neutral

July 30, 2026 5:58 AM EDT Send to a Friend
(Updated - July 30, 2026 5:59 AM EDT)

H.C. Wainwright analyst Joseph Pantginis downgraded Capricor Therapeutics (NASDAQ: CAPR) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login